Liquidia Corporation remains a Buy for risk-tolerant biotech investors, supported by strong Yutrepia launch metrics and ...
The ocean has always looked like a blank blue expanse on most maps, yet beneath that surface lies a layered, living ...
Partnership to help BioMarin increase speed and efficiency in developing and commercializing innovative therapiesPLEASANTON, Calif., and SAN RAFAEL, Calif., Jan. 8, 2026 /PRNewswire/ -- Veeva ...